tiprankstipranks
International Stem Cell (ISCO)
OTHER OTC:ISCO
US Market
Holding ISCO?
Track your performance easily

International Stem Cell (ISCO) Income Statement

43 Followers

International Stem Cell Income Statement

Last quarter (Q ), International Stem Cell's total revenue was $2.18M, an increase of 18.36% from the same quarter last year. In Q, International Stem Cell's net income was $-125.00K. See International Stem Cell’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 8.61M$ 7.79M$ 8.18M$ 7.18M$ 7.13M$ 9.47M
Cost of Revenue
$ 3.56M$ 3.18M$ 3.27M$ 9.10M$ 9.95M$ 3.93M
Gross Profit
$ 5.06M$ 4.61M$ 4.91M$ 7.18M$ 7.13M$ 5.54M
Operating Expense
$ 6.05M$ 5.27M$ 5.09M$ 9.10M$ 7.17M$ 11.27M
Operating Income
$ -216.00K$ -663.00K$ -183.00K$ -1.92M$ -2.82M$ -5.73M
Net Non Operating Interest Income Expense
$ -140.00K$ -139.00K$ -135.00K$ -128.00K$ -113.00K$ -77.00K
Other Income Expense
$ 24.00K$ 671.00K$ -13.00K$ -1.15M$ -207.00K$ -1.54M
Pretax Income
$ -408.00K$ -131.00K$ -331.00K$ -899.00K$ -2.72M$ -4.26M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -351.00K$ -262.00K$ -331.00K$ -899.00K$ -2.72M$ -4.26M
Basic EPS
$ -0.06$ -0.02$ -0.04---
Diluted EPS
$ -0.06$ -0.02$ -0.04$ -0.11$ -0.36$ -0.57
Basic Average Shares
$ 32.02M$ 8.00M$ 8.00M$ 7.83M$ 7.54M$ 7.51M
Diluted Average Shares
$ 32.02M$ 8.00M$ 8.00M$ 7.83M$ 7.54M$ 7.51M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 10.90M$ 8.45M$ 8.36M$ 18.19M$ 17.11M$ 15.20M
Net Income From Continuing And Discontinued Operation
$ -351.00K$ -131.00K$ -331.00K$ -899.00K$ -2.72M$ -4.26M
Normalized Income
$ -394.72K-----
Interest Expense
------
EBIT
$ -211.00K$ 8.00K$ -196.00K$ -771.00K$ -2.61M$ -4.19M
EBITDA
$ -12.00K$ 202.00K$ 22.00K$ -509.00K$ -2.36M$ -3.90M
Currency in USD

International Stem Cell Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis